首页> 外文期刊>Ophthalmology >Conservative treatment of early and moderate pellucid marginal degeneration: a new refractive approach with intracorneal rings.
【24h】

Conservative treatment of early and moderate pellucid marginal degeneration: a new refractive approach with intracorneal rings.

机译:早期和中度透明性边缘变性的保守治疗:采用角膜内环的新屈光方法。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: To evaluate the use of the intracorneal ring (ICR; Intacs, Addition Technology, Inc., Fremont, CA) for the treatment of pellucid marginal degeneration (PMD). DESIGN: Case series. PARTICIPANTS: Eight patients with PMD who were intolerant to contact lenses received ICR segments in the superior cornea (0.25 mm thickness) and in the inferior cornea (0.45 mm thickness). The diagnosis was supported by Orbscan II tomography (Bausch & Lomb). MAIN OUTCOME MEASURES: Preoperative and postoperative uncorrected visual acuity, best spectacle-corrected visual acuity (BSCVA), refractive astigmatism, and spherical equivalent were assessed. Changes in corneal shape were evaluated by corneal tomographic maps. RESULTS: The minimum follow-up was 12 months (range, 12-42 months; standard deviation [SD], 14.14). Uncorrected visual acuity improved in all 8 eyes (100%). At the last postoperative examination, 6 eyes (75%) had a BCVA > or =20/25; mean postoperative refractive astigmatism was -2.53 (range, -4.50 to -1.25; SD, 1.03). Mean postoperative spherical equivalent was -1.52 (range, -7.25 to +1.87; SD, 3.01). At the third postoperative month, refractive stability was obtained. No patients lost any Snellen lines of BCVA. No intraoperative and postoperative complications occurred. CONCLUSIONS: Intracorneal ring implantation is a promising new treatment for patients with early to moderate PMD and who are intolerant of contact lenses.
机译:目的:评估角膜内环(ICR; Intacs,Addition Technology,Inc.,Fremont,CA)在治疗透明边缘变性(PMD)中的应用。设计:案例系列。参与者:8例不耐受隐形眼镜的PMD患者在上角膜(0.25毫米厚)和下角膜(0.45毫米厚)接受了ICR分割。诊断得到Orbscan II断层扫描(Bausch&Lomb)的支持。主要观察指标:评估术前和术后未矫正的视力,最佳眼镜矫正的视力(BSCVA),屈光散光和等效球镜。通过角膜断层摄影图评估角膜形状的变化。结果:最小随访时间为12个月(范围12-42个月;标准差[SD]为14.14)。所有8眼(100%)的未矫正视力均得到改善。在最后一次术后检查中,有6眼(75%)的BCVA>或= 20/25;术后平均屈光散光为-2.53(范围-4.50至-1.25; SD为1.03)。术后平均球形当量为-1.52(范围为-7.25至+1.87; SD为3.01)。术后第三个月,获得屈光稳定性。没有患者丢失任何Snellen BCVA品系。术中无术后并发症发生。结论:对于早期至中度PMD且不能耐受隐形眼镜的患者,角膜内环植入术是一种有前途的新疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号